Protein τ-Mediated Effects on Rat Hippocampal Choline Transporters CHT1 and τ-Amyloid β Interactions
- 4 July 2013
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 38 (9) , 1949-1959
Abstract
It is suggested that intracellular tau protein (τ), when released extracellularly upon neuron degeneration, could evoke direct toxic effects on the cholinergic neurotransmitter system through muscarinic receptors and thus contribute to the pathogenesis of Alzheimer’s disease. In this study, we evaluated the in vitro effects of six naturally occurring monomeric τ isoforms on rat hippocampal synaptosomal choline transporters CHT1 (large transmembrane proteins associated with high-affinity choline transport and vulnerable to actions of amyloid β peptides (Aβ) applied in vitro or in vivo). Some τ isoforms at nM concentrations inhibited choline transport in a dose- and time-dependent saturable manner (352 = 441 > 410 = 383 > 381 = 412) and effects were associated with changes in the Michaelis constant rather than in maximal velocity. Moreover, the actions of τ 352/441 were not influenced by previous depolarisation of synaptosomes or by previous depletion of membrane cholesterol. Specific binding of [3H]hemicholinium-3 was not significantly altered by τ 352/441 at higher nM concentrations. Results of in vitro tests on CHT1 transporters from cholesterol-depleted synaptosomes supported interactions between Aβ 1-40 and τ 352. In addition, we developed surface plasmon resonance biosensors to monitor complexes of Aβ 1-42 and τ 352 using a sandwich detection format. It seems, therefore, that protein τ, similar to Aβ peptides, can contribute to the pathogenesis of Alzheimer’s disease through its actions on CHT1 transporters. However, the interaction mechanisms are quite different (τ probably exerts its effects through direct interactions of microtubule binding repeats with extracellular portions of the CHT1 protein without influencing the choline recognition site, Aβ rather through lipid rafts in the surrounding membranes). An N-terminal insert of τ is not necessary but the N-terminal projection domain plays a role. The developed biosensor will be used to detect Aβ–τ complexes in cerebrospinal fluid in order to evaluate them as prospective biomarkers of Alzheimer′s disease.Keywords
This publication has 33 references indexed in Scilit:
- Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injuryBrain, 2011
- Tissue-nonspecific Alkaline Phosphatase Promotes the Neurotoxicity Effect of Extracellular TauJournal of Biological Chemistry, 2010
- Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau FilamentsPLOS ONE, 2010
- Intracellular and extracellular tauFrontiers in Neuroscience, 2010
- Complementary dimerization of microtubule-associated tau protein: Implications for microtubule bundling and tau-mediated pathogenesisProceedings of the National Academy of Sciences, 2008
- Interaction of tau protein with the dynactin complexThe EMBO Journal, 2007
- Formaldehyde at Low Concentration Induces Protein Tau into Globular Amyloid-Like Aggregates In Vitro and In VivoPLOS ONE, 2007
- Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons – implications for Alzheimer's diseaseEuropean Journal of Neuroscience, 2007
- Cortical load of PHF-tau in Alzheimer's disease is correlated to cholinergic dysfunctionJournal of Neural Transmission, 1999
- Amyloid β‐Peptide Inhibits High‐Affinity Choline Uptake and Acetylcholine Release in Rat Hippocampal SlicesJournal of Neurochemistry, 1998